SCOLR Pharma Inc (AMEX:DDD) to Hold Q3 2008 Earnings Conference Call November 7

SCOLR Pharma, Inc (AMEX:DDD) will hold a conference call on Friday, November 7 at 8:30 am ET to discuss the third quarter earnings for 2008.  Interested parties may hear the call by dialing 888-713-4215 or 617-213-4867 for international callers.  The access code for the call is 67625263.  A live webcast of the presentation will also be available on scolr.com.

SCOLR Pharma, Inc. is a specialty pharmaceutical company. SCOLR is an acronym for Self-Correcting Oral Linear Release, a feature of the Company’s lead technology. The Company’s utilizes its Controlled Delivery Technology (CDT) platform to develop pharmaceutical, over-the-counter (OTC) and nutritional products.

SCOLR Pharma has developed multiple private label extended-release nutritional products incorporating its CDT platform that are sold by United States retailers. The Company is engaged in development of CDT-based extended-release formulations of ibuprofen, pseudoephedrine, ondansetron, rivastigmine, and risperidone, as well as an immediate-release formulation of raloxifene.

Read more Business News on The Global Market Directory.

About The Global Market Directory (TheGMD)

TheGMD is a financial networking community for Public Companies, Brokerage Firms, Stock Brokers and Individuals. Members can network and link with each other, participate in discussions on financial stock message boards, display pictures and upload videos.

The GMD is a member of the TransWorldNews, Inc. family of sites. Members can distribute press releases through The GMD and receive distribution over all TransWorldNews news outlets.

Create your profile on The Global Market Directory